An intrinsically labile a-helix abutting the BCL9-binding site of ß-catenin is required for its inhibition by carnosic acid. (2012)

First Author: De La Roche M
Attributed to:  Expansion of MRCTs Drug Discovery Group (DDG) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/ncomms1680

PubMed Identifier: 22353711

Publication URI: http://europepmc.org/abstract/MED/22353711

Type: Journal Article/Review

Volume: 3

Parent Publication: Nature communications

ISSN: 2041-1723